Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease

References

• Boasso A, Herbeuval JP, Hardy AW, et al. (2005). Regulation of indoleamine 2,3-dioxygenase and tryptophanyltRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105:1574–81
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Yilmaz MI, Lindholm B, Stenvinkel P. (2008). Cytokine dysregulation in chronic kidney disease. Blood Purif 26:291–9
   PubMed Web of Science ®Google Scholar
• Chung DJ, Rossi M, Romano E, et al. (2009). Indoleamine 2,3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114:555–63
   PubMed Web of Science ®Google Scholar
• Criado G, Simelyte E, Inglis JJ, et al. (2009). Indoleamine 2,3-dioxygenase-mediated tryptophan catabolism regulates accumulation of th1/th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 60:1342–51
   PubMedGoogle Scholar
• Descamps-Latcha B. (1993). The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 2:883–91
   Google Scholar
• Descamps-Latscha B, Jungers P, Witko-Sarsat V. (2002). Immune system dysregulation in uremia: role of oxidative stress. Blood Purif 20:481–4
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Vacca C, et al. (2002). T cell apoptosis by tryptophan catabolism. Cell Death Differ 9:1069–77
   PubMed Web of Science ®Google Scholar
• Fleckner J, Martensen PM, Tolstrup AB, et al. (1995). Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7:70–7
   PubMedGoogle Scholar
• Gurtner GJ, Newberry RD, Schloemann SR, et al. (2003). Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125:1762–73
   PubMed Web of Science ®Google Scholar
• Hayashi T, Beck L, Rossetto C, et al. (2004). Inhibition of experimental asthma by indoleamine 2,3- dioxygenase. J Clin Invest 114:270–9
   PubMed Web of Science ®Google Scholar
• Hung AM, Crawford DC, Griffin MR, et al. (2010). CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol 5:24–33
   Google Scholar
• Katz JB, Muller AJ, Prendergast GC. (2008). Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222:206–21
   PubMed Web of Science ®Google Scholar
• Kwidzinski E, Bunse J, Aktas O, et al. (2005). Indoleamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19:1347–9
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–70
   PubMed Web of Science ®Google Scholar
• Libetta C, Rampino T, Dal Canton A. (2001). Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 38:286–95
   PubMed Web of Science ®Google Scholar
• Mellor A. (2005). Indoleamine 2,3-dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338:20–4
   PubMed Web of Science ®Google Scholar
• Mellor AL, Baban B, Chandler P, et al. (2003). Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171:1652–5
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. (2004). IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762–74
   PubMed Web of Science ®Google Scholar
• Mohib K, Guan Q, Diao H, et al. (2007). Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells. Am J Physiol Renal Physiol 293:F801–12
   Google Scholar
• Mohib K, Wang S, Guan Q, et al. (2008). Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 295:F226–34
   Web of Science ®Google Scholar
• Munn DH, Mellor AL. (2007). Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147–54
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, et al. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191–3
   PubMed Web of Science ®Google Scholar
• Murray MF. (2003). Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect Dis 3:644–52
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory board. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney disease outcome quality initiative. Am J Kidney Dis 39:S1–246
   Google Scholar
• Outinen TK, Makela SM, Ala-Houhala IO, et al. (2011). High Activity of Indoleamine 2,3-Dioxygenase Is Associated With Renal Insufficiency in Puumala Hantavirus Induced Nephropathia Epidemica. J Med Virol 83:731–7
   PubMed Web of Science ®Google Scholar
• Schefold JC, Zeden JP, Fotopoulou C, et al. (2009). Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 24:1901–8
   PubMed Web of Science ®Google Scholar
• Sester U, Sester M, Hauk M, et al. (2000). T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 15:1217–23
   PubMed Web of Science ®Google Scholar
• Tonelli M, Sacks F, Pfeffer M, et al. (2005). Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–45
   PubMed Web of Science ®Google Scholar
• Widner B, Werner ER, Schennach H, et al. (1997). Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424–2
   PubMed Web of Science ®Google Scholar
• Williams CA, Harry RA, McLeod JD. (2008). Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. Immunology 124:89–101
   PubMed Web of Science ®Google Scholar